Sharp Chula Vista Medical Center is a hospital in Chula Vista, California, in the United States. Founded in 1979, Sharp Chula Vista is part of Sharp HealthCare, a San Diego health care company. Sharp Chula Vista has 343 beds, including 100 skilled nursing beds and 9 neonatal intensive care unit beds.

There are 343 beds in Sharp Chula Vista Medical Center.

During the past decade, Sharp Chula Vista Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sharp Chula Vista Medical Center" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sharp Chula Vista Medical Center" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sharp Chula Vista Medical Center" are "Crohn Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Stroke" (2 trials), "Abscess" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "Sharp Chula Vista Medical Center" in a lesser frequency.

Most popular intervention types in "Sharp Chula Vista Medical Center" are "Drug" (16 trials), "Device" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "Abiraterone Acetate" (1 trials), "Apalutamide" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sharp Chula Vista Medical Center" are 16 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sharp Chula Vista Medical Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sharp Chula Vista Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sharp Chula Vista Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".